Regorafenib (REGO) is a synthetic oral multi-kinase inhibitor with potent antitumor activity. In this study, we investigate the molecular mechanisms by which REGO induces apoptosis. REGO induced ...
Statistical comparisons were made using unpaired two-tailed Student’s t-test with Prism v8.0 software (GraphPad, San Diego, CA, USA). Data are shown as means ± SEM with P ≤ 0.05 considered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results